MK-4716 / Merck (MSD) - LARVOL DELTA

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001) (clinicaltrials.gov) - P1 | N=250 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting

Enrollment open • Monotherapy • Oncology • Solid Tumor

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001) (clinicaltrials.gov) - P1 | N=250 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC

Monotherapy • New P1 trial • Oncology • Solid Tumor